Latest filing published 03 Nov 2026 for Regeneron Pharmaceuticals, INC., €257k.
Filing timeline
BuySaleInsider track record
Kathryn Guarini: trading record in brief
This profile gathers the share dealings of Kathryn Guarini in Regeneron Pharmaceuticals, Inc. In total, 10 filings cover trades dated from 8 September 2023 to 30 October 2026.
No open-market purchase appears, only 3 sales worth €892k. The rest of the record consists of 4 share grants and 3 option exercises. Since January 2026: no purchases and 3 sales on the market.
The record was last updated on 3 November 2026 with an option exercise (€257k) in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kathryn Guarini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 shares@ US$719.37Common StockSEC:0001992352-26-000009:0
- 400 shares@ US$900.00Common StockSEC:0001992352-26-000009:1
- 400 shares@ US$719.370.0003% mcap23.3% of flowCommon StockSEC:0001992352-26-000007:0
- 400 shares@ US$850.000.0004% mcap27.5% of flowCommon StockSEC:0001992352-26-000007:1
- 400 shares@ US$719.370.0003% mcap23.3% of flowCommon StockSEC:0001992352-26-000005:0
- 155 shares0Common StockSEC:0001992352-26-000003:0
- 166 shares0Common StockSEC:0001968202-25-000005:0
- 42 shares0Common StockSEC:0001883850-24-000002:0
- 240 shares0Common StockSEC:0001104659-23-099988:0
9 of 9 declarations
